11-72106043-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001393500.2(TOMT):c.92T>G(p.Val31Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000438 in 1,550,986 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001393500.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOMT | NM_001393500.2 | c.92T>G | p.Val31Gly | missense_variant | Exon 1 of 3 | ENST00000541899.3 | NP_001380429.1 | |
LRTOMT | NM_001145308.5 | c.191T>G | p.Val64Gly | missense_variant | Exon 5 of 7 | NP_001138780.1 | ||
LRTOMT | NM_001145309.4 | c.191T>G | p.Val64Gly | missense_variant | Exon 7 of 9 | NP_001138781.1 | ||
LRTOMT | NM_001145310.4 | c.84-13T>G | intron_variant | Intron 6 of 8 | NP_001138782.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOMT | ENST00000541899.3 | c.92T>G | p.Val31Gly | missense_variant | Exon 1 of 3 | 5 | NM_001393500.2 | ENSP00000494667.1 | ||
LRTOMT | ENST00000307198.11 | c.191T>G | p.Val64Gly | missense_variant | Exon 5 of 7 | 2 | ENSP00000305742.7 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152074Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000388 AC: 6AN: 154528Hom.: 0 AF XY: 0.0000487 AC XY: 4AN XY: 82064
GnomAD4 exome AF: 0.0000436 AC: 61AN: 1398794Hom.: 1 Cov.: 30 AF XY: 0.0000464 AC XY: 32AN XY: 689952
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74402
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Val64Gly variant in LRTOMT has not been previously reported in individuals w ith hearing loss or in large population studies. Computational prediction tools and conservation analysis suggest that this variant may impact the protein, thou gh this information is not predictive enough to determine pathogenicity. In summ ary, the clinical significance of the Val64Gly variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.191T>G (p.V64G) alteration is located in exon 5 (coding exon 3) of the LRTOMT gene. This alteration results from a T to G substitution at nucleotide position 191, causing the valine (V) at amino acid position 64 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 179867). This variant has not been reported in the literature in individuals affected with LRTOMT-related conditions. This variant is present in population databases (rs574631765, gnomAD 0.01%). This sequence change replaces valine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 64 of the LRTOMT protein (p.Val64Gly). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at